Host cell signalling during HTLV-1 infection: novel insights and interventions

Funding Activity

Website
http://purl.org/au-research/grants/nhmrc/GNT1133538

Funding Status
Closed

Does something not look right? The information on this page has been harvested from data sources that may not be up to date. We continue to work with information providers to improve coverage and quality. To report an issue, use the .

Funded Activity Summary

Human T-leukemia virus 1 (HTLV-1) establishes a life-long infection and causes cancer and immune dysfunction. This study aims to find a cure for HTLV-1 by inducing the specific death of infected cells using novel therapeutic drugs that target host cell death pathways. Dead infected cells are then naturally cleared from the system along with the viral infection. The impact of HTLV-1 infection on tuberculosis severity will also be examined.

Funded Activity Details

Start Date: 01-01-2017

End Date: 01-01-2019

Funding Scheme: Postgraduate Scholarships

Funding Amount: $62,335.00

Funder: National Health and Medical Research Council

Research Topics

ANZSRC Field of Research (FoR)

Medical Virology

ANZSRC Socio-Economic Objective (SEO)

There are no SEO codes available for this funding activity

Other Keywords

cell death | infectious diseases | pre-clinical studies | signalling pathways | therapeutic agents

Related Links